Grace Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.13

+0.01 (+0.47%)

As of Aug 8, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +984.0% upside

Low Target $18.68

Average Target $23.09

High Target $33.94

Current Price $2.13

Current
$2.13

Target
$23.09

$18.68 $23.09 avg $33.94

Scenario Analysis

Bear Case

$18.68

777.0%

Low target

Base Case

$23.09

+984.0%

Avg target

Bull Case

$33.94

+1,493.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$5.18

-58.9% from high

52-Week Low

$1.79

+19.0% from low

Target vs 52W High

$23.09

+345.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%